Developer docs
API playgroundTry for free, no card

Search company profiles

AventuSoft

Full company profile

uuid0002rpt

Namestring
AventuSoft
Legal namestring
Aventusoft LLC
Websiteurl
aventusoft.com
Company typeenum
Private
Founded yearint
2014
Descriptiontext

AventuSoft LLC is a privately held Boca Raton, Florida healthcare technology company founded in 2014 to commercialize signal-detection technology originally developed for the Department of Defense. The company operates a portfolio of three AI-enabled products. Its flagship, HEMOTAG CPAS, is a non-invasive, rechargeable, reusable, cloud-connected cardiac diagnostic system that uses everyday smartphones and proprietary sensors to assess left ventricular systolic function, diastolic function, left ventricular pressure, congestion, and lead-1 ECG vital signs without requiring a skilled operator; sensor data is sent to a HIPAA-compliant cloud, analyzed with machine-learning algorithms, and delivered to the care team as an electronic patient report within minutes. CarePear is a tele-care platform that connects patients with US-based sub-specialists across endocrinology, rheumatology, hematology, oncology, pulmonology, and pediatric specialties via secure video consultation, with consent, medical-history, and payment functionality built in. Trialogy is an AI-driven decentralized clinical trials platform positioned for the life sciences market.

The company generates revenue through a mix of hardware and software sales of HEMOTAG to hospitals and clinics, subscription and usage access to CarePear, clinical study services delivered to health system partners such as Cleveland Clinic Florida and HCA-JFK Hospital, and non-dilutive research funding from NIH institutes (NHLBI, NIDDK, NIBIB, NIMHD), NSF, and DARPA via the SBIR/STTR programs. Go-to-market combines direct enterprise engagement with hospitals, OB/GYN clinics, primary care offices, emergency medical services, and community clinics, alongside US Commercial Service-supported international expansion into Costa Rica and Panama. Key customers and clinical partners include Cleveland Clinic Florida, HCA-JFK Hospital, the University of Miami Miller School of Medicine at JFK Campus, UF Health, Baylor Scott & White Health, the Caja Costarricense de Seguro Social, and multiple private Central American hospitals.

Short descriptiontext

AventuSoft is a privately held Boca Raton healthcare AI company that builds HEMOTAG, a non-invasive cloud-connected cardiac diagnostic device, alongside the CarePear tele-care platform and Trialogy decentralized clinical trials platform, selling to hospitals and clinics.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersBoca Raton, United States
HQ citystring
Boca Raton
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
cardiac diagnostics device, tele-care platform, remote hemodynamic monitoring, decentralized clinical trials, AI medical diagnostics
Industry3 codes
PRIMARYHLAHAFAI
Hemodynamic Monitoring & Cardiac Diagnostics (Cath Lab, FFR/IVUS/OCT)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Cardiovascular Devices (Stents, Valves, Rhythm Management)
SECONDARYHLACAPAI
Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
SECONDARYHLALAFAA
Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity)
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms
NAICS code2 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing33451
SIC code2 codes
  • Electromedical & Electrotherapeutic Apparatus3845
  • Surgical & Medical Instruments & Apparatus3841
Product category
Cardiac Diagnostic Devices
Social media profiles2 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model4 records
1HEMOTAG Device Sales
TypeHardware Sales
Description

Sale of HEMOTAG cardiac diagnostic hardware devices and associated software platform to healthcare providers and institutions

aventusoft.com
2CarePear Tele-Care Platform
TypeSubscription Recurring
Description

Subscription or usage-based access to tele-care platform enabling video consultations with US-based specialist physicians

aventusoft.com
3NIH/DARPA Research Grants
TypeLicensing Royalties
Description

Government funding through SBIR/STTR grants from NIH institutes (NHLBI, NIDDK, NIBIB, NIMHD) and DARPA for product development and clinical trials

aventusoft.com
4Clinical Trial Services
TypeProfessional Services
Description

Revenue from clinical study partnerships with major hospital systems (Cleveland Clinic, JFK Medical Center) for product validation and expanded indications

aventusoft.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Technology or R&D, Operations, Marketing or Sales
Pricing details1 tier
1Enterprise Healthcare Pricing
ModelOtherBilling cadenceMulti-year contract
Notes

Pricing not publicly disclosed. Direct engagement with healthcare institutions for device and platform deployment.

aventusoft.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 3 records shown
1Hemotag
Description

Device and digital health AI platform for non-invasive cardiac diagnostics and remote monitoring, providing hemodynamic assessment of cardiac pressure and function.

aventusoft.com
+2 more records
Core offering1 text field

AventuSoft develops and sells the HEMOTAG non-invasive cardiac diagnostic hardware device paired with a HIPAA-compliant cloud AI/ML analytics platform that assesses left ventricular systolic/diastolic function, left ventricular pressure, congestion, and lead-1 ECG vital signs. The company also operates CarePear, a tele-care platform connecting patients to US-based sub-specialists, and Trialogy, an AI-driven decentralized clinical trials platform.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 146% revenue growth over two-year period (2019-2021)
+3 more records
Product overview1 text field

AventuSoft is a healthcare technology firm offering a portfolio of three distinct products focused on cardiac health and telehealth: Hemotag (non-invasive cardiac diagnostics device and cloud AI platform), CarePear (tele-care platform connecting patients with US-based specialists), and Trialogy (AI-driven decentralized clinical trials platform). Hemotag serves as the core cardiac monitoring solution with AI-powered diagnostics, CarePear extends specialist access through telehealth consultations, and Trialogy supports clinical research. All products leverage cloud connectivity and AI/ML capabilities for remote patient monitoring and care delivery.

Product and service3 records
1HEMOTAG CPAS Cardiac Diagnostic System
CategoryCardiac Diagnostic Device
Description

Non-invasive, rechargeable, reusable, secure cloud-connected device and digital health platform for cardiac diagnostics and remote monitoring. Provides assessment of left ventricular systolic function, diastolic function, left ventricular pressure, congestion, and lead-1 ECG-based vital-sign assessment. Sold to healthcare providers and institutions including hospitals, OB/GYN clinics, primary care offices, and emergency medical services.

2CarePear Tele-Care Platform
CategoryTelehealth Platform
Description

AI health platform enabling patients and physicians to access US-based sub-specialists via video consultation with bank-grade HIPAA-compliant security. Covers Endocrinology, Rheumatology, Hematology, Oncology, Pulmonology, and Pediatric specialties. Allows patients to sign intake/consent forms, update medical history, and upload medical records. Accessed via desktop, tablet, or smartphone.

3Trialogy
CategoryClinical Research Platform
Description

AI-driven decentralized clinical trials platform enabling the future of clinical research by connecting life science with AI.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership9 partners
1Cleveland Clinic Florida
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Clinical trial partner for HEMOTAG CPAS congestive heart failure studies. Studies led by Advanced Heart Disease and Transplant Cardiologist Jaime Hernandez-Montfort, MD and Robert Cubeddu, MD from Cleveland Clinic Florida. Tier 1 hospital research partner.

aventusoft.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Clinical trial site for HEMOTAG CPAS studies encompassing clinical and health economic outcome data from 420 patients. Led by Robert Chait, MD and Waqas Ghumman, MD.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Academic medical center partnership providing cardiology fellowship program and clinical trial oversight. Steven Borzak, MD serves as Associate Program Director.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

In 2018, Aventusoft was selected by Research Park at FAU to receive funding for GrowFL's strategic research economic gardening initiative. Aventusoft is a member of the Florida Atlantic University Health Network.

Strategic tierCoreTypeGTM or Marketing Partner
Description

Trade promotion arm of U.S. Department of Commerce assisting U.S. firms in selling products around the world. Aventusoft participated as Certified Trade Mission and Gold Key service member for Central American market entry.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Academic health system partner for clinical studies. Ali Ataya, MD serves as Cardiologist and PI Clinical Studies at UF Health.

7Baylor Scott & White Health
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Healthcare system partner for clinical studies. Jaime Hernandez-Monfort, MD serves as Advanced Heart Failure Cardiologist and PI Clinical Studies.

aventusoft.com
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

CarePear trade mission partners including Caja Costarricense de Seguro Social (CCSS), Camara Costarricense de la Salud, Hospital Clínica Bíblica, Hospital CIMA, Hospital Metropolitano for connecting patients with US-based specialists.

9Panama Healthcare Institutions
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

CarePear trade mission partners including Asociación Panameña de Cardiología, Asociación Panameña de Medicina Familiar, Clínica Panamá, Punta Pacífica Hospital for tele-care platform distribution.

aventusoft.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Develops non-invasive, continuous hemodynamic monitoring devices (VitalStream) that measure blood pressure, cardiac output, and other hemodynamic parameters without catheters. Directly comparable to HEMOTAG's non-invasive hemodynamic assessment approach.

TypeDirect peer
Description

Offers wearable, AI-powered remote patient monitoring devices capturing continuous vital signs and hemodynamic parameters including blood pressure, stroke volume, and cardiac output. Competes with HEMOTAG in non-invasive AI-driven cardiac monitoring.

TypeBroad incumbent
Description

Global leader in hemodynamic monitoring (Swan-Ganz catheters) and structural heart disease. Represents the established standard-of-care invasive approach that non-invasive technologies like HEMOTAG aim to displace.

TypeBroad incumbent
Description

Markets Starling SV, a non-invasive hemodynamic monitoring system using bioreactance. Closest large-cap analog to HEMOTAG's non-invasive cardiac output/pressure measurement value proposition.

TypeDirect peer
Description

Provides non-invasive, AI-driven cardiac diagnostic analysis (FFR-CT) that avoids invasive catheterization. Directly comparable mission to HEMOTAG of replacing invasive cardiac diagnostics with non-invasive AI-based assessment.

TypeDirect peer
Description

AI-powered ambulatory cardiac monitoring (Zio patch) for arrhythmia detection, with cloud-based analytics. Comparable model of combining a wearable cardiac sensor with cloud AI for diagnostic insights.

TypeBroad incumbent
Description

Major medical device incumbent offering cardiac monitoring, ECG, and remote patient monitoring solutions across hospital and ambulatory settings. Represents the established competition in cardiac diagnostics.

TypeEmerging player
Description

Large-scale telehealth platform connecting patients to physicians across specialties. Comparable to AventuSoft's CarePear platform in offering specialist access via remote consultations.

TypeEmerging player
Description

Decentralized clinical trials platform enabling remote patient participation in studies. Directly comparable to AventuSoft's Trialogy product category.

TypeBroad incumbent
Description

Large incumbent in cardiac diagnostics, patient monitoring, and AI-enabled healthcare analytics. Represents the broader competitive and potential partnership/buyer landscape for HEMOTAG and the AI platform.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

AventuSoft

Cardiac Diagnostic Devicesaventusoft.com

AventuSoft is a privately held Boca Raton healthcare AI company that builds HEMOTAG, a non-invasive cloud-connected cardiac diagnostic device, alongside the CarePear tele-care platform and Trialogy decentralized clinical trials platform, selling to hospitals and clinics.

What AventuSoft does

AventuSoft LLC is a privately held Boca Raton, Florida healthcare technology company founded in 2014 to commercialize signal-detection technology originally developed for the Department of Defense. The company operates a portfolio of three AI-enabled products. Its flagship, HEMOTAG CPAS, is a non-invasive, rechargeable, reusable, cloud-connected cardiac diagnostic system that uses everyday smartphones and proprietary sensors to assess left ventricular systolic function, diastolic function, left ventricular pressure, congestion, and lead-1 ECG vital signs without requiring a skilled operator; sensor data is sent to a HIPAA-compliant cloud, analyzed with machine-learning algorithms, and delivered to the care team as an electronic patient report within minutes. CarePear is a tele-care platform that connects patients with US-based sub-specialists across endocrinology, rheumatology, hematology, oncology, pulmonology, and pediatric specialties via secure video consultation, with consent, medical-history, and payment functionality built in. Trialogy is an AI-driven decentralized clinical trials platform positioned for the life sciences market.

The company generates revenue through a mix of hardware and software sales of HEMOTAG to hospitals and clinics, subscription and usage access to CarePear, clinical study services delivered to health system partners such as Cleveland Clinic Florida and HCA-JFK Hospital, and non-dilutive research funding from NIH institutes (NHLBI, NIDDK, NIBIB, NIMHD), NSF, and DARPA via the SBIR/STTR programs. Go-to-market combines direct enterprise engagement with hospitals, OB/GYN clinics, primary care offices, emergency medical services, and community clinics, alongside US Commercial Service-supported international expansion into Costa Rica and Panama. Key customers and clinical partners include Cleveland Clinic Florida, HCA-JFK Hospital, the University of Miami Miller School of Medicine at JFK Campus, UF Health, Baylor Scott & White Health, the Caja Costarricense de Seguro Social, and multiple private Central American hospitals.

AventuSoft firmographics

Firmographics
Name
AventuSoft
Legal name
Aventusoft LLC
Website
https://aventusoft.com
Company type
Private
Founded year
2014
Operating status
Operating
Headcount range
11–50 employees
Short description
AventuSoft is a privately held Boca Raton healthcare AI company that builds HEMOTAG, a non-invasive cloud-connected cardiac diagnostic device, alongside the CarePear tele-care platform and Trialogy decentralized clinical trials platform, selling to hospitals and clinics.
Ownership category
akta.pro rank

AventuSoft industry classification

Industry
Product category
Cardiac Diagnostic Devices
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)
SIC
Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLAHAFAI
Hemodynamic Monitoring & Cardiac Diagnostics (Cath Lab, FFR/IVUS/OCT)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Cardiovascular Devices (Stents, Valves, Rhythm Management)
SECONDARYHLACAPAI
Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
SECONDARYHLALAFAA
Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity)
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms

Keywords

  • Cardiac diagnostics device
  • Tele-care platform
  • Remote hemodynamic monitoring
  • Decentralized clinical trials
  • AI medical diagnostics

Where AventuSoft is headquartered

Location

Headquarters

HQ city
Boca Raton
HQ country
United States
HQ region
North America

Offices1 record

Markets served

AventuSoft business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales

Revenue model

  1. HEMOTAG Device Sales: Sale of HEMOTAG cardiac diagnostic hardware devices and associated software platform to healthcare providers and institutions
  2. CarePear Tele-Care Platform: Subscription or usage-based access to tele-care platform enabling video consultations with US-based specialist physicians
  3. NIH/DARPA Research Grants: Government funding through SBIR/STTR grants from NIH institutes (NHLBI, NIDDK, NIBIB, NIMHD) and DARPA for product development and clinical trials
  4. Clinical Trial Services: Revenue from clinical study partnerships with major hospital systems (Cleveland Clinic, JFK Medical Center) for product validation and expanded indications

Pricing tiers

ModelBillingPrice
OtherMulti-year contractEnterprise Healthcare Pricing

Go-to-market motion2 records

Distribution channels2 records

Marketing channels4 records

AventuSoft product offering

Product offering

Core offering

AventuSoft develops and sells the HEMOTAG non-invasive cardiac diagnostic hardware device paired with a HIPAA-compliant cloud AI/ML analytics platform that assesses left ventricular systolic/diastolic function, left ventricular pressure, congestion, and lead-1 ECG vital signs. The company also operates CarePear, a tele-care platform connecting patients to US-based sub-specialists, and Trialogy, an AI-driven decentralized clinical trials platform.

Product overview

AventuSoft is a healthcare technology firm offering a portfolio of three distinct products focused on cardiac health and telehealth: Hemotag (non-invasive cardiac diagnostics device and cloud AI platform), CarePear (tele-care platform connecting patients with US-based specialists), and Trialogy (AI-driven decentralized clinical trials platform). Hemotag serves as the core cardiac monitoring solution with AI-powered diagnostics, CarePear extends specialist access through telehealth consultations, and Trialogy supports clinical research. All products leverage cloud connectivity and AI/ML capabilities for remote patient monitoring and care delivery.

Differentiator

Problem solved

Functional benefit

Brands

  • Hemotag: Device and digital health AI platform for non-invasive cardiac diagnostics and remote monitoring, providing hemodynamic assessment of cardiac pressure and function.
  • CarePear
  • Trialogy

Products and services

  • HEMOTAG CPAS Cardiac Diagnostic System Non-invasive, rechargeable, reusable, secure cloud-connected device and digital health platform for cardiac diagnostics and remote monitoring. Provides assessment of left ventricular systolic function, diastolic function, left ventricular pressure, congestion, and lead-1 ECG-based vital-sign assessment. Sold to healthcare providers and institutions including hospitals, OB/GYN clinics, primary care offices, and emergency medical services.
  • CarePear Tele-Care Platform AI health platform enabling patients and physicians to access US-based sub-specialists via video consultation with bank-grade HIPAA-compliant security. Covers Endocrinology, Rheumatology, Hematology, Oncology, Pulmonology, and Pediatric specialties. Allows patients to sign intake/consent forms, update medical history, and upload medical records. Accessed via desktop, tablet, or smartphone.
  • Trialogy AI-driven decentralized clinical trials platform enabling the future of clinical research by connecting life science with AI.

Quantifiable outcome

  • 146% revenue growth over two-year period (2019-2021)
  • +3 more outcomes

Companies that use AventuSoft

Customer profile

Named customers5 records

Segments3 records

Ideal customer profiles2 records

AventuSoft technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature4 records

AventuSoft partnerships and signals

Strategic signal

Partnerships

Nine partnerships are on record, tiered core and minor.

  • Cleveland Clinic FloridacoreStrategic or Co-development PartnerClinical trial partner for HEMOTAG CPAS congestive heart failure studies. Studies led by Advanced Heart Disease and Transplant Cardiologist Jaime Hernandez-Montfort, MD and Robert Cubeddu, MD from Cleveland Clinic Florida. Tier 1 hospital research partner.
  • HCA-JFK HospitalcoreStrategic or Co-development PartnerClinical trial site for HEMOTAG CPAS studies encompassing clinical and health economic outcome data from 420 patients. Led by Robert Chait, MD and Waqas Ghumman, MD.
  • University of Miami Miller School of Medicine at JFK CampuscoreStrategic or Co-development PartnerAcademic medical center partnership providing cardiology fellowship program and clinical trial oversight. Steven Borzak, MD serves as Associate Program Director.
  • Florida Atlantic University (FAU) Research ParkminorStrategic or Co-development PartnerIn 2018, Aventusoft was selected by Research Park at FAU to receive funding for GrowFL's strategic research economic gardening initiative. Aventusoft is a member of the Florida Atlantic University Health Network.
  • U.S. Commercial Service / International Trade AdministrationcoreGTM or Marketing PartnerTrade promotion arm of U.S. Department of Commerce assisting U.S. firms in selling products around the world. Aventusoft participated as Certified Trade Mission and Gold Key service member for Central American market entry.
  • UF HealthminorStrategic or Co-development PartnerAcademic health system partner for clinical studies. Ali Ataya, MD serves as Cardiologist and PI Clinical Studies at UF Health.
  • Baylor Scott & White HealthminorStrategic or Co-development PartnerHealthcare system partner for clinical studies. Jaime Hernandez-Monfort, MD serves as Advanced Heart Failure Cardiologist and PI Clinical Studies.
  • Costa Rica Healthcare InstitutionsminorChannel Partner/ Reseller/ DistributorCarePear trade mission partners including Caja Costarricense de Seguro Social (CCSS), Camara Costarricense de la Salud, Hospital Clínica Bíblica, Hospital CIMA, Hospital Metropolitano for connecting patients with US-based specialists.
  • Panama Healthcare InstitutionsminorChannel Partner/ Reseller/ DistributorCarePear trade mission partners including Asociación Panameña de Cardiología, Asociación Panameña de Medicina Familiar, Clínica Panamá, Punta Pacífica Hospital for tele-care platform distribution.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

AventuSoft competitors and assessment

Company assessment

Direct peers

  • Caretaker Medical: Develops non-invasive, continuous hemodynamic monitoring devices (VitalStream) that measure blood pressure, cardiac output, and other hemodynamic parameters without catheters. Directly comparable to HEMOTAG's non-invasive hemodynamic assessment approach.
  • Biobeat: Offers wearable, AI-powered remote patient monitoring devices capturing continuous vital signs and hemodynamic parameters including blood pressure, stroke volume, and cardiac output. Competes with HEMOTAG in non-invasive AI-driven cardiac monitoring.
  • HeartFlow: Provides non-invasive, AI-driven cardiac diagnostic analysis (FFR-CT) that avoids invasive catheterization. Directly comparable mission to HEMOTAG of replacing invasive cardiac diagnostics with non-invasive AI-based assessment.
  • iRhythm Technologies: AI-powered ambulatory cardiac monitoring (Zio patch) for arrhythmia detection, with cloud-based analytics. Comparable model of combining a wearable cardiac sensor with cloud AI for diagnostic insights.

Broad incumbents

  • Edwards Lifesciences: Global leader in hemodynamic monitoring (Swan-Ganz catheters) and structural heart disease. Represents the established standard-of-care invasive approach that non-invasive technologies like HEMOTAG aim to displace.
  • Baxter International (Starling SV): Markets Starling SV, a non-invasive hemodynamic monitoring system using bioreactance. Closest large-cap analog to HEMOTAG's non-invasive cardiac output/pressure measurement value proposition.
  • Philips (Cardiac Monitoring): Major medical device incumbent offering cardiac monitoring, ECG, and remote patient monitoring solutions across hospital and ambulatory settings. Represents the established competition in cardiac diagnostics.
  • GE HealthCare: Large incumbent in cardiac diagnostics, patient monitoring, and AI-enabled healthcare analytics. Represents the broader competitive and potential partnership/buyer landscape for HEMOTAG and the AI platform.

Emerging players

  • Teladoc Health: Large-scale telehealth platform connecting patients to physicians across specialties. Comparable to AventuSoft's CarePear platform in offering specialist access via remote consultations.
  • Medable: Decentralized clinical trials platform enabling remote patient participation in studies. Directly comparable to AventuSoft's Trialogy product category.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

AventuSoft social profiles

Digital presence

AventuSoft compliance and trust

Trust signal

Compliance2 records

AventuSoft financial estimates

Financial estimate

Revenue estimate

Valuation estimate

AventuSoft leadership team

Management profile

Number of profiles

Profiles7 records

AventuSoft subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

AventuSoft funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

AventuSoft M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AventuSoft

What does AventuSoft do?

AventuSoft develops and sells the HEMOTAG non-invasive cardiac diagnostic hardware device paired with a HIPAA-compliant cloud AI/ML analytics platform that assesses left ventricular systolic/diastolic function, left ventricular pressure, congestion, and lead-1 ECG vital signs. The company also operates CarePear, a tele-care platform connecting patients to US-based sub-specialists, and Trialogy, an AI-driven decentralized clinical trials platform.

Is AventuSoft a public or private company?

AventuSoft is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was AventuSoft founded?

AventuSoft was founded in 2014. It employs 11 to 50 people.

Where is AventuSoft based?

AventuSoft is headquartered in Boca Raton, United States, in the North America region.

How does AventuSoft make money?

Four revenue lines are on record. HEMOTAG Device Sales are the primary driver. The others are carePear Tele-Care Platform, NIH/DARPA Research Grants and clinical Trial Services.

Who are AventuSoft's main competitors?

Direct peers on record are Caretaker Medical, Biobeat, HeartFlow and iRhythm Technologies. Broad incumbents are Edwards Lifesciences, Baxter International (Starling SV), Philips (Cardiac Monitoring) and GE HealthCare. Emerging players are Teladoc Health and Medable.

Does AventuSoft have an API?

No public API is recorded for AventuSoft.

What industry is AventuSoft in?

AventuSoft's product category is Cardiac Diagnostic Devices. Its primary akta.pro industry code is HLAHAFAI, Hemodynamic Monitoring & Cardiac Diagnostics (Cath Lab, FFR/IVUS/OCT), with a secondary code of HLACAPAI, Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration). Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales